Under the collaboration Foundation Medicine will use its genomic sequencing and analytical capabilities to assess potentially relevant molec...
You must be logged in to view the whole article.
Click here if you require signing up
Ceregene unveils more Phase IIb data for Parkinson's disease gene therapy CERE-120
Sunovion unveils encouraging data from two studies of Latuda for bipolar depression
SQI Diagnostics' Q2 FY 2013 net loss remains unchanged Y/Y
Ignyta enters oncology personalised drug market via Actagene Oncology buy
Personal Genome Diagnostics, Blueprint Medicines join hands on new kinase targets identification
Bayer announces positive data from PAH treatment trial
Acorda Therapeutics Inc receives additional US Patent for AMPYRA covering range of dosage strengths
Biogen seeks FDA approval of peginterferon beta-1a for multiple sclerosis
Pfizer discontinues Phase 3 Study of Inotuzumab Ozogamicin due to futility
Medivir reports encouraging Phase Ia findings for MIV-711 for skeletal conditions
Intercept Phase IIA trial with obeticholic acid shows improvement in acid diarrhea
Peregrine, FDA agree on Phase III study design for bavituximab in NSCLC
FDA nods to expanded indication of Intercell's Japanese Encephalitis vaccine